Abstract
The purpose of this study was to determine the point prevalence of depressive symptoms, using the PRIME-MD questionnaire, and irritable bowel syndrome (IBS), while comparing the Rome II to the Rome I criteria, in patients with fibromyalgia (FM) and rheumatologic controls in an outpatient setting. The prevalence of IBS in FM patients (n = 105) was 63% by Rome I and 81% by Rome II criteria. The prevalence of IBS in controls (n = 62) was 15% by Rome I and 24% by Rome II criteria (FM vs. control; P < 0.001). Depressive symptoms were met in 40% of FM patients and 8% of controls (P < 0.001). The coexistence of IBS and depressive symptoms in the FM patients was 31% (Rome I) and 34% (Rome II). The prevalence of IBS and depressive symptoms was higher in FM patients compared to the control population. Identification of IBS and depressive symptoms in FM patients might enable clinicians to better meet the needs of this patient population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Offenbaecher M, Glatzeder K, Ackenheil M: Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 57 (Suppl 2):94–96, 1998
Burckhardt CS, O’Reilly CA, Wiens AN, Clark SR, Campbell SM, Bennett RM: Assessing depression in fibromyalgia patients. Arthritis Care Res 7:35–39, 1994
Vanner SJ, Depew WT, Paterson WG, et al.: Predictive value of the rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 94:2912–2917, 1999
Pace F, Sarzi-Puttini P, Manzionna G: Visceral hypersensitivity is not a feature of fibromyalgia syndrome. J Musculoskel Pain 9:47–55, 2001
Sperber AD, Atzmon Y, Neumann L, et al.: Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications. Am J Gastroenterol 94:3541–3546, 1999
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA: Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl 2):II43–II47, 1999
Ercolani M, Trombini G, Chattat R, et al.: Fibromyalgic syndrome: Depression and abnormal illness behavior. multicenter investigation. Psychother Psychosom 61:178–186, 1994
Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 282:1737–1744, 1999
Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arth Rheum 33:160–172, 1990
Thompson WG, Dotevall G, Drossman DA, Heaton KW: Irritable bowel syndrome: Guidelines for the diagnosis and functional abdominal pain. Gastroenterol Int 2:92–95, 1989
Triadafilopoulos G, Simms RW, Goldenberg DL: Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 36:59–64, 1991
Drossman DA, Sandler RS, McKee DC, Lovitz AJ: Bowel patterns among subjects not seeking health care. use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 83:529–534, 1982
Mearin F, Roset M, Badia X, et al.: Splitting irritable bowel syndrome: From original Rome to Rome II criteria. Am J Gastroenterol 99:122–130, 2004
Mearin F, Balboa A, Badia X, et al.: Irritable bowel syndrome subtypes according to bowel habit: Revisiting the alternating subtype. Eur J Gastroenterol Hepato 115:165–172, 2003
Katon W, Schulberg H: Epidemiology of depression in primary care. Gen Hosp Psychiatry 14:237–247, 1992
Rush J, Hay B: Depression guideline panel: Depression in primary care, detection and diagnosis, clinical practice guideline. AHCPR 1, 1993
Abdel-Nasser AM, Abd El-Azim S, Taal E, El-Badawy SA, Rasker JJ, Valkenburg HA: Depression and depressive symptoms in rheumatoid arthritis patients: An analysis of their occurrence and determinants. Br J Rheumatol 37:391–397, 1998
Soderlin MK, Hakala M, Nieminen P: Anxiety and depression in a community-based rheumatoid arthritis population. Scand J Rheumatol 29:177–183, 2000
Boyce PM, Koloski NA, Talley NJ: Irritable bowel syndrome according to varying diagnostic criteria: Are the new rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 95:3176–3183, 2000
Giesecke T, Williams DA, Harris RE, et al.: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arth Rheum 48:2916–2922, 2003
Chang L: The association of functional gastrointestinal disorders and fibromyalgia. Eur J Surg Suppl 583:32–36, 1998
Mertz H, Morgan V, Tanner G, et al.: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118:842–848, 2000
Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 112:64–72, 1997
Chang L, Berman S, Mayer EA, et al.: Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 98:1354–1361, 2003
Pimentel M, Wallace D, Hallegua D, et al.: A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 63:450–452, 2004
Author information
Authors and Affiliations
Corresponding author
Additional information
The views expressed in this article are those of the authors and do not reflect the official policy or practice of the Department of the Navy, Department of Defense, or the United States Government. This research was performed at outpatient private rheumatology clinics. No financial support was received for the research
Rights and permissions
About this article
Cite this article
Kurland, J.E., Coyle, W.J., Winkler, A. et al. Prevalence of Irritable Bowel Syndrome and Depression in Fibromyalgia. Dig Dis Sci 51, 454–460 (2006). https://doi.org/10.1007/s10620-006-3154-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-3154-7